EMC Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,753
Closed -$42K 328
2022
Q1
$42K Sell
2,753
-139,565
-98% -$2.13M 0.03% 292
2021
Q4
$2.19M Buy
142,318
+2,361
+2% +$31.1K 1.18% 14
2021
Q3
$1.42M Buy
139,957
+35,689
+34% +$325K 0.79% 32
2021
Q2
$1.06M Buy
104,268
+8,346
+9% +$88.1K 0.6% 47
2021
Q1
$1.15M Buy
95,922
+38,325
+67% +$435K 0.82% 39
2020
Q4
$524K Buy
+57,597
New +$446K 0.4% 73

Other funds holding NPTN

EMC Capital Management's NPTN Position: Q2 2022 in Review

EMC Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2022, closing a stake of 2,753 shares — an estimated $42K sold.

EMC Capital Management first reported a position in NPTN in Q4 2020 and held it in 6 quarters. The position peaked at $2.19M in Q4 2021. 156 funds tracked by Wall St. Rank hold NPTN as of Q2 2022.

  • EMC Capital Management reported no remaining NEOPHOTONICS CORP position as of Q2 2022 after selling out during the quarter.
  • EMC Capital Management sold 2,753 NEOPHOTONICS CORP shares in Q2 2022, an estimated $42K.
  • EMC Capital Management first reported a position in NEOPHOTONICS CORP in Q4 2020 and held it in 6 quarters.
  • EMC Capital Management's NEOPHOTONICS CORP position peaked at $2.19M in Q4 2021.
  • 156 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2022.

Based on EMC Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.